Medical Developments International Ltd
XBER:M5D
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Medical Developments International Ltd
XBER:M5D
|
AU |
|
A
|
Alkane Resources Ltd
SWB:AK7
|
AU |
|
Customers Bancorp Inc
F:334
|
US |
|
D
|
Dr Reddy's Laboratories Ltd
BSE:500124
|
IN |
|
A
|
Alkane Resources Ltd
F:AK7
|
AU |
|
S
|
Silver47 Exploration Corp
OTC:SVEXF
|
CA |
|
C
|
Conagra Brands Inc
DUS:CAO
|
US |
|
Cybertech Systems and Software Ltd
NSE:CYBERTECH
|
IN |
|
Hipages Group Holdings Ltd
ASX:HPG
|
AU |
Wall St Price Targets
M5D Price Targets Summary
Medical Developments International Ltd
According to Wall Street analysts, the average 1-year price target for M5D is 0.52 EUR with a low forecast of 0.515 EUR and a high forecast of 0.536 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is M5D's stock price target?
Price Target
0.52
EUR
According to Wall Street analysts, the average 1-year price target for M5D is 0.52 EUR with a low forecast of 0.515 EUR and a high forecast of 0.536 EUR.
What is the Revenue forecast for Medical Developments International Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 4 years is 11%.
What is the Net Income forecast for Medical Developments International Ltd?
Projected CAGR
222%
Over the last 13 years, the compound annual growth rate for Net Income has been -23%. The projected CAGR for the next 4 years is 222%.
